2022
DOI: 10.1038/s41574-022-00717-z
|View full text |Cite
|
Sign up to set email alerts
|

Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 241 publications
0
17
0
Order By: Relevance
“…Excessive body weight and obesity have been related to elevated betatrophin levels and the risk of developing metabolic syndrome in non‐pregnant women, although moderate and intense physical activity may reduce betatrophin levels 61 . In pregnant women, GDM and excessive body weight are risk factors for both the mother and the offspring due to the associated reduced available foetal oxygen secondary to the insulin stimulation of the foetal metabolism 62,63 . However, experimental studies support a neutralising betatrophin effect on insulin resistance, 64,65 reducing tissue inflammation and weight gain, and improving glucose tolerance 66 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Excessive body weight and obesity have been related to elevated betatrophin levels and the risk of developing metabolic syndrome in non‐pregnant women, although moderate and intense physical activity may reduce betatrophin levels 61 . In pregnant women, GDM and excessive body weight are risk factors for both the mother and the offspring due to the associated reduced available foetal oxygen secondary to the insulin stimulation of the foetal metabolism 62,63 . However, experimental studies support a neutralising betatrophin effect on insulin resistance, 64,65 reducing tissue inflammation and weight gain, and improving glucose tolerance 66 …”
Section: Discussionmentioning
confidence: 99%
“…61 In pregnant women, GDM and excessive body weight are risk factors for both the mother and the offspring due to the associated reduced available foetal oxygen secondary to the insulin stimulation of the foetal metabolism. 62,63 However, experimental studies support a neutralising betatrophin effect on insulin resistance, 64,65 reducing tissue inflammation and weight gain, and improving glucose tolerance. 66 The meta-analysed women with GDM had higher prepregnancy and pregnancy BMI than the control group.…”
Section: Main Findings and Interpretationmentioning
confidence: 99%
“…It is characterized by excessive maternal insulin resistance and hyperglycemia, resulting in fetal hyperglycemia, hyperinsulinemia, and growth abnormalities 188,189 . Hyperglycemia and hyperinsulinemia may accelerate fetal metabolism but impair oxygen delivery to the placenta, and cause hypoxia 189–191 . Increased glycolysis/gluconeogenesis and decreased fatty acid metabolism are generally accepted as characteristics of GDM 192,193 …”
Section: Glycolysis In Pathological Pregnancymentioning
confidence: 99%
“…188,189 Hyperglycemia and hyperinsulinemia may accelerate fetal metabolism but impair oxygen delivery to the placenta, and cause hypoxia. [189][190][191] Increased glycolysis/gluconeogenesis and decreased fatty acid metabolism are generally accepted as characteristics of GDM. 192,193 Hyperglycemia during GDM leads to altered placental glucose uptake.…”
Section: Gestational Diabetes Mellitusmentioning
confidence: 99%
“…Anemia in pregnancy is a condition of the decrease in blood cell levels or hemoglobin levels (Bhadra & Deb, 2020). It causes the oxygen level transported as the needs of important organs in the mother and fetus in the womb are reduced (Desoye & Carter, 2022). So, it can be one of the risk factors for low birth weight babies (LBW) (Amri et al, 2020).…”
Section: Introductionmentioning
confidence: 99%